Recently, Reigncom Biotech formally completed its first round of financing worth tens of millions of yuan. The round was led by ZGC Capital, a subsidiary of ZGC GROUP, with follow-on investment from ZGC Science City Ltd. The funds will be primarily used for core team building, continuous iteration of the AI research agent work platform and industrial-grade cross-scale intelligent computing engine, construction of an automated experimental verification system, and further expansion and implementation of industrial application scenarios.

Reigncom Biotech is a sci-tech achievement commercialization enterprise incubated and led by a team of academicians and renowned scientists. Focusing on AI4M (AI for Materials), the company is dedicated to promoting the deep integration of artificial intelligence and materials science. Centered on key domains including AI research agents, intelligent computing, and materials data, the company has built an AI4M Intelligent R&D Platform that spans the entire materials R&D lifecycle. It provides one-stop solutions for intelligent design, computing, and independent R&D of new materials for high-tech fields such as advanced functional ceramics, alloys, and new energy. The company strives to overcome the long cycles and high costs that have constrained traditional materials R&D.

Notably, ZGC Group has built a competitive edge in sci-tech achievement commercialization and industrialization by tailoring its investment strategy to sources of innovation, including national laboratories, key national laboratories, new R&D institutions, leading research universities, and research institutes. The Group has invested in a number of sci-tech achievement commercialization projects, including those from academician teams led by Shi Yigong, Wang Xiaodong, and Luo Yi.